![Samir Mitragotri](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Samir Mitragotri first degree
Entity | Entity type | Industry | |
---|---|---|---|
I2o Therapeutics, Inc.
![]() I2o Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
CAGE Bio, Inc.
![]() CAGE Bio, Inc. BiotechnologyHealth Technology CAGE Bio, Inc. transforms ionic liquids into healthcare solutions. Its ionic liquid platform uses structural heterogeneity of cations and anions to enhance membrane permeation. The company was founded by Nitin Joshi and Samir Mitragotri and is headquartered in San Carlos, CA.
2
| Holding Company | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Samir Mitragotri via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
The University of North Carolina at Chapel Hill | College/University | Doctorate Degree | |
Roger Williams University | College/University | Undergraduate Degree | |
Sanofi Ventures
![]() Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Alevium Pharmaceuticals, Inc. | Director/Board Member | ||
PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
SERES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Hillsdale College | College/University | Undergraduate Degree | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
RADIUS HEALTH, INC. | Biotechnology | Chairman | |
Intarcia Therapeutics, Inc.
![]() Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Executive Officer | |
Pulmatrix Operating Co., Inc.
![]() Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member | |
Astra Merck, Inc.
![]() Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Director/Board Member | |
Minervax ApS
![]() Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member |
Statistics
International
United States | 18 |
Denmark | 2 |
Sectoral
Health Technology | 12 |
Consumer Services | 4 |
Finance | 2 |
Retail Trade | 2 |
Distribution Services | 2 |
Operational
Director/Board Member | 11 |
Chairman | 5 |
Chief Executive Officer | 4 |
Corporate Officer/Principal | 4 |
Founder | 4 |
Most connected contacts
Insiders | |
---|---|
Kurt Graves | 15 |
Christopher Gagliardi | 5 |
Ravi Srinivasan | 2 |
Kelly Ibsen | 1 |
Tyler Brown | 1 |
Nitin Joshi | 1 |
- Stock Market
- Insiders
- Samir Mitragotri
- Company connections